Long-Term Pharmacotherapy for Post-Traumatic Stress Disorder

  title={Long-Term Pharmacotherapy for Post-Traumatic Stress Disorder},
  author={Lori L. Davis and Elizabeth C Frazier and Raela B Williford and Jason M. Newell},
  journal={CNS Drugs},
This article reviews the literature on the long-term pharmacological treatment of post-traumatic stress disorder (PTSD). A PUBMED search was conducted; only studies on the effects of long-term (>14-weeks) pharmacological treatment for PTSD in adults or children were considered. Our search identified three randomised, double-blind, placebo-controlled studies (one each for sertraline, fluoxetine and risperidone), four open-label studies (one each for sertraline, paroxetine, nefazodone and… 
Antiepileptic drugs for the treatment of post-traumatic stress disorder
  • H. Berlin
  • Psychology
    Current psychiatry reports
  • 2007
The possibility that AEDs may be effective in the treatment of PTSD due to their antikindling effect is discussed, and suggestions for future research are made.
Posttraumatic Stress Disorder: Overview of Evidence-Based Assessment and Treatment
A review of the characteristics of PTSD along with associated risk factors, and brief, evidence-based measures that can be used to screen for PTSD and monitor symptom changes over time are provided.
Patient-reported outcomes in post-traumatic stress disorder Part II: Focus on pharmacological treatment
  • H. Kapfhammer
  • Psychology, Medicine
    Dialogues in clinical neuroscience
  • 2014
Two different pharmacotherapeutic trends that aim to modify the encoding, consolidation, and rehearsal of traumatic memory in order to reduce the risk of PTSD immediately after trauma exposure are outlined and that endeavor to treat the clinical state of PTSD on the other.
Psychopharmacological treatment for military posttraumatic stress disorder: An integrative review
Studies to date indicate that SSRIs are only moderately effective as a first‐line treatment for PTSD and less so for military personnel, and propranolol has the ability to attenuate traumatic memory in primary and tertiary use.
Gender Differences in the Psychological Sequelae of Childhood and Adulthood Physical Abuse
Conventional pharmacological treatment of posttraumatic stress disorder (PTSD) consists of SSRIs. This class of medicine has been shown to be effective in treating both shortand long-term symptoms of
Pharmacological treatment of combat-induced PTSD: a literature review.
  • D. Bastien
  • Psychology, Medicine
    British journal of nursing
  • 2010
This literature review provides some insight into the risks and benefits of three groups of drugs commonly prescribed for combat-induced PTSD: beta-blockers, selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines (BZDs).
From non-pharmacological interventions to therapeutic targets for the treatment of PTSD
It was shown that EE and RE are very effective strategies to treat PTSD in an animal model and the discoveries that the neuropeptide Y1 receptor (Y1) and the corticotropin-releasing factor receptor 1 (CRFR1) are involved in this recovery are examples of therapeutic target discovery using non-pharmacological interventions.
Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans.
Although use targeted specifically to PTSD and to comorbid disorders was common, substantial use appeared to be unrelated to diagnosis and may be targeted at specific symptoms rather than diagnosed illnesses.


Pharmacotherapy for post-traumatic stress disorder: a comprehensive review
There are virtually no data on pharmacotherapy for acute stress reaction or for PTSD in children, and future directions for research may focus on combination treatment in the more treatment-resistant patient populations.
Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.
The acute efficacy of sertraline is sustained in the vast majority of patients, and at least half of nonresponders to acute treatment will eventually respond to continued treatment.
Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
The data suggest that sertraline is a safe, well-tolerated, and effective treatment for PTSD.
Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.
Sertraline treatment of chronic PTSD is associated with rapid improvement in quality of life that is progressive and sustained over the course of more than 1 year of treatment.
Treatment-Resistant Posttraumatic Stress Disorder: Strategies for Intervention
This review will address representative existing studies and discuss several potential pharmacologic strategies for patients suffering from treatment refractory PTSD.
Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.
The results of the current study suggest that sertraline is a safe, well-tolerated, and significantly effective treatment for PTSD.
Sertraline: A Review of its Therapeutic Use in Post-Traumatic Stress Disorder
Sertraline has demonstrated efficacy in the treatment of PTSD, particularly in female patients and in non-combat-induced PTSD, and is generally well tolerated, and appears to have a lower potential for drug interactions than other SSRIs, although direct comparisons are lacking.
Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder
Fluoxetine is effective and well tolerated in the prevention of PTSD relapse for up to 6 months and is less likely to relapse than patients in the fluoxettine/placebo group.
Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.
Evidence is provided for the ability of sertraline both to sustain improvement in PTSD symptoms and to provide prophylactic protection against relapse in patients with posttraumatic stress disorder who had completed a 12-week double-blind, placebo-controlled acute treatment study and a subsequent 24-week open-label study of continuation treatment with sertrals.
WCA Recommendations for the Long-Term Treatment of Posttraumatic Stress Disorder
Treatment for PTSD includes psychotherapy and pharmacotherapy, which includes selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and monoamine oxidase inhibitors, which have been proven effective and safe in long-term randomized controlled trials.